# [AI for Biomedicine in the Era of Large Language Models](https://arxiv.org/abs/2403.15673)

## Write a very high-quality and detailed summary of the paper that describes the paper in a way that a human can fully understand. The summary should cover the problem, the proposed solution and highlight the main contributions of the paper.

 Here is a detailed summary of the key points from the paper:

Problem: 
With recent advances in large language models (LLMs) like ChatGPT for natural language tasks, an intriguing question arises - can we leverage LLMs to drive discoveries in biomedicine using the three key types of biomedical data: textual, biological sequences, and brain signals? These data types resemble language in their sequential structure. 

Proposed Solution:
This paper explores the application of LLMs to the three biomedical data types to harness their potential for biomedical insights. 

Key Contributions:

1) LLMs on Biomedical Textual Data:
- Reviews transformer-based models like SciBERT, ClinicalBERT, BioBERT, and recent models like BioMegatron, SciFive, PubMedBERT, BioLinkBERT, Galactica, BioGPT, etc.
- Discusses clinical applications like treatment planning and research applications like information extraction.

2) LLMs on Biological Sequences: 
- Discusses application to DNA (models like Enformer, Nucleotide Transformer), RNA (RNABERT, RNA-FM), protein (ProteinBERT, ESM-1b) and multi-omics (scBERT, Geneformer) sequences.
- Models predict structures, interactions, functions and associations with diseases.

3) LLMs on Brain Signals:
- Introduces models like BrainBERT, MMM, LaBraM for pre-training representations from EEG signals. 
- Discusses applications in decoding signals to text, images and other modalities.

Overall, the paper provides a comprehensive overview of emerging research at the intersection of large language models and biomedicine spanning diverse data types. It highlights state-of-the-art models, promising applications and exciting future directions in this rapidly evolving field.


## Summarize the paper in one sentence.

 Here is a one-sentence summary of the paper:

This paper provides a comprehensive survey of the application of large language models to three key types of biomedical data - textual, biological sequences, and brain signals - discussing innovative models in each domain, their downstream applications, and remaining challenges around trustworthiness, personalization, and multi-modality.


## What is the main contribution of this paper?

 This paper provides a comprehensive survey of the application of large language models (LLMs) to three key types of biomedical data: textual data, biological sequences, and brain signals.

The main contributions are:

1) Reviewing various LLMs proposed for biomedical textual data and their applications in areas like biomedical information extraction and question answering. Models discussed include SciBERT, ClinicalBERT, BioBERT, BioMegatron, SciFive, PubMedBERT, BioLinkBERT, Galactica, BioGPT, DoT5, GatorTronGPT, and Med-PaLM 2.

2) Surveying genomic LLMs for DNA, RNA, and protein sequences, as well as multi-omics sequencing data, along with their utilities in predicting structures, functions, interactions, etc. Specific models highlighted include Enformer, Nucleotide Transformer, GenSLMs, DNABERT, GENA-LM, HyenaDNA for DNA; RNABERT, RNA-FM, RNA-MSM for RNA; protein structure understanding models like ESM-1b and protein generation models like LM-Design.  

3) Introducing brain signal LLMs like BrainBERT, MMM, and LaBraM, and their applications in areas such as brain-to-text translation, brain-to-image translation, voice decoding from EEG, and motion decoding.

4) Discussing key challenges with using LLMs in biomedicine regarding trustworthiness, personalization, and handling multi-modal biomedical data representations.

Overall, the paper provides a foundation for bridging LLMs with biomedical research by comprehensively surveying their intersection across diverse biomedical data types.


## What are the keywords or key terms associated with this paper?

 Based on my review of the paper's content, some of the key terms and keywords associated with this paper include:

- Large language models (LLMs)
- Biomedicine 
- Textual data
- Biological sequences 
- DNA sequences
- RNA sequences
- Protein sequences  
- Multi-omics sequencing data
- Brain signals 
- EEG signals
- Downstream applications
- Model pre-training 
- Self-supervised learning
- Transfer learning
- Text generation
- Sequence analysis
- Structure prediction
- Brain-computer interfaces

The paper provides a comprehensive survey of applying large language models to three key types of biomedical data: textual data, biological sequences, and brain signals. It reviews various models for pre-training and fine-tuning LLMs on these data types to enable downstream prediction and generation tasks. The key capabilities, architectures, training techniques, datasets, evaluation tasks, and applications are summarized for major models across each data type. The paper also discusses challenges and future directions related to ensuring reliability, achieving personalization, and handling multi-modal biomedical data with LLMs. Overall, the central themes focus on harnessing recent advances in large language models to drive innovation and discoveries in the biomedical domain.


## Design 10 in-depth questions about the method proposed in this paper and avoid simple questions.

 Here are 10 potential in-depth questions about the methods proposed in this paper:

1. The paper discusses using large language models (LLMs) for diverse types of biomedical data. What are some of the key challenges and considerations when applying LLMs developed for natural language to biomedical domains? How can the models be adapted to handle the unique aspects of biomedical data?

2. For applying LLMs to biomedical textual data, the paper highlights models like SciBERT, BioBERT, and PubMedBERT. How do these models differ in their pre-training strategies and objectives? What tradeoffs exist between pre-training on general scientific text versus domain-specific corpora? 

3. When using LLMs for biological sequences, what are some of the key differences in modeling capabilities needed for DNA versus RNA versus protein sequences? What unique challenges exist in effectively learning from raw sequential biological data?

4. The paper discusses recent models like Enformer, GenSLMs, and HyenaDNA for analyzing DNA sequences. How do these models incorporate long-range interactions in DNA or leverage evolutionary information? What are their limitations?

5. For RNA analysis, the paper introduces innovations like RNABERT and RNA-MSM. How do these models integrate structural details alongside sequential RNA data? What additional information is needed alongside RNA sequences for better functional understanding?

6. What are the different overall objectives behind recent protein LLMs - is the focus more on sequence understanding, generation, or multi-modal integration? What datasets and model architectures best serve each of those goals? 

7. The paper talks about models like scBERT, Geneformer, scFoundation and scGPT for multi-omics data. What are the key differences in their approaches and applications? What challenges do they aim to address compared to traditional single cell analysis?

8. For analyzing complex brain signals, what novel pre-training methods are proposed by models like BrainBERT, MMM and LaBraM? How do they aim to overcome limitations like data variability and scarcity?

9. What are some of the recent advancements discussed in areas like EEG-to-text and EEG-to-image translation? What key technical innovations have enabled these applications?

10. What do you see as the most promising directions for future work in terms of model scale, multi-modality, personalization, trustworthiness, etc. for LLMs in biomedicine? What open challenges need to be addressed?
